127
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Impact of Brief, Sequential Exposure to Fluconazole and Amphotericin B on the Cell Surface Hydrophobicity of oral Candida albicans Isolates Obtained from HIV Infected Patients

&
Pages 153-159 | Published online: 11 Jul 2009

  • Arendorf TM, Bredekamp B, Cloete CAC, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998; 27: 176-9.
  • Odds FC. Candida and Candidosis: a Review and Bibliography. London: Bailliere Tindall, 1994.
  • Ruechel R. Virulence factors of Candida species. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis. London: Wright, 1990: 47-65.
  • Samaranayake LP, Ellepola ANB. Studying Candida albicans adhesion. In: An YH, Friedman RJ, eds. Handbook of Bacterial Adhesion. Clifton: Humana, 2000: 527-40.
  • Hazen KC, Hazen BW. Hydrophobie surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect Immun 1992; 60: 1499-508.
  • Ellepola ANB, Samaranayake LP. The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells. Arch Oral Biol 1998; 43: 879-87.
  • Antley PP, Hazen KC. Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect Immun 1988; 56: 2884-90.
  • Hazen KC, Hazen BW. Dynamic expression of cell surface hydrophobicity during initial cell growth before germ tube formation of C. albicans. Infect Immun 1988; 56: 2521-5.
  • Ellepola ANB, Samaranayake LP. Oral candidat infections and antimycotics. Crit Rev Oral Biol Med 2000; 11: 17298.
  • Egusa H, Ellepola ANB, Nikawa H, Hamada T, Samaranayake LP. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates. J Oral Pathol Med 2000; 29: 206-13.
  • Hazen KC, Mandell G, Coleman E, Wu G. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans. FEMS Microbiol Lett 2000; 183: 89-94.
  • Ellepola ANB, Samaranayake LP. The post-antifungal effect (PAFE) of antimycotics on oral Canada albicans isolates and its impact on candidat adhesion. Oral Dis 1998; 4: 260-7.
  • Ellepola ANB, Samaranayake LP. The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J Oral Pathol Med 1999; 28: 112-6.
  • Sweet SP, MacFarlane TW, Samaranayake LP. Determination of cell surface hydrophobicity of oral bacteria using a modified hydrocarbon adherence method. FEMS Microbiol Lett 1987; 48: 159-63.
  • McGinnis MR, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids. In: Lorian V, ed. Antibiotics in Laboratory Medicine. Baltimore: Williams and Wilkins, 1996: 176-211.
  • White TC, Marr KA, Bowden RA. Clinical cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.